- Joined
- Jul 10, 2014
- Messages
- 17,957
- Reaction score
- 30,156
- Points
- 113
A proven Treatment for Covid and the FDA just banned it
This is all out war on America. Meanwhile they sited "injection complications" but they push the covid vaccine which has killed tens or hundreds of thousands that we know of...
[h=1]FDA bans Lilly, Regeneron antibody use in COVID-19 patients infected by omicron[/h]
https://www.fiercepharma.com/pharma...on-antibodies-banning-their-use-against-those
The FDA has trimmed the authorization for monoclonal antibodies made by Eli Lilly and Regeneron as recent data suggests they are not effective against the omicron variant currently driving a wave of COVID-19 infections.
In response, the FDA has now revised emergency use authorizations for the Lilly and Regeneron antibodies, limiting their use to patients who have been infected with or exposed to a variant that is susceptible to the treatments.
The FDA has trimmed the authorization for monoclonal antibodies made by Eli Lilly and Regeneron as recent data suggests they are not effective against the omicron variant currently driving a wave of COVID-19 infections.
In response, the FDA has now revised emergency use authorizations for the Lilly and Regeneron antibodies, limiting their use to patients who have been infected with or exposed to a variant that is susceptible to the treatments.
This is all out war on America. Meanwhile they sited "injection complications" but they push the covid vaccine which has killed tens or hundreds of thousands that we know of...
[h=1]FDA bans Lilly, Regeneron antibody use in COVID-19 patients infected by omicron[/h]
https://www.fiercepharma.com/pharma...on-antibodies-banning-their-use-against-those
The FDA has trimmed the authorization for monoclonal antibodies made by Eli Lilly and Regeneron as recent data suggests they are not effective against the omicron variant currently driving a wave of COVID-19 infections.
States have been distributing the antibody drugs to treat COVID-19 patients even as omicron became the dominant strain in the U.S. and elsewhere. But data from the companies themselves has suggested the antibodies developed earlier in the pandemic are no longer effective. In response, the FDA has now revised emergency use authorizations for the Lilly and Regeneron antibodies, limiting their use to patients who have been infected with or exposed to a variant that is susceptible to the treatments.
The FDA has trimmed the authorization for monoclonal antibodies made by Eli Lilly and Regeneron as recent data suggests they are not effective against the omicron variant currently driving a wave of COVID-19 infections.
States have been distributing the antibody drugs to treat COVID-19 patients even as omicron became the dominant strain in the U.S. and elsewhere. But data from the companies themselves has suggested the antibodies developed earlier in the pandemic are no longer effective. In response, the FDA has now revised emergency use authorizations for the Lilly and Regeneron antibodies, limiting their use to patients who have been infected with or exposed to a variant that is susceptible to the treatments.